Nora M. Barnes-Horowitz

Nora M. Barnes-Horowitz

Auto-generated profile, based on publicly available information

Nora M. Barnes-Horowitz

University of California, Los Angeles, Department of Psychology, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2023 in JMIR Mental Health
Verified
Journal Article
Open access
KWKate Wolitzky-Taylor
Kate Wolitzky-Taylor
RLRichard LeBeau
Richard LeBeau
IAInna Arnaudova
Inna Arnaudova
NBNora Barnes-Horowitz
Nora Barnes-Horowitz
EGElizabeth Gong-Guy
Elizabeth Gong-Guy
MCMichelle Craske
Michelle Craske
Background: The global burden of anxiety and depression has created an urgent need for scalable approaches to increase access to evidence-based mental health care. The Screening and Treatment for Anxiety and Depression (STAND) system of care was developed to meet this need through the use of internet-connected devices for assessment and provision of treatment. STAND triages to level of care (monitoring only, digital therapy with coaches, digital therapy assisted by clinicians in training, and clinical care) and then continuously monitors symptoms to adapt level of care. Triaging and adaptation are based on symptom severity and suicide risk scores obtained from computerized adaptive testing administered remotely. Objective: This article discusses how the STAND system of care improves upon current clinical paradigms, and presents preliminary data on feasibility, acceptability, and effectiveness of STAND in a sample of US-based university students. Methods: US-based university students were recruited and enrolled in an open trial of the STAND system of care. Participants were triaged based on initial symptom severity derived from a computerized adaptive test and monitored over 40 weeks on anxiety, depression, and suicide risk to inform treatment adaptation and evaluate preliminary effectiveness. Results: Nearly 5000 students were screened and 516 received care. Depression and anxiety severity scores improved across all tiers (P<.001 in all cases). Suicide risk severity improved in the highest tier (ie, clinical care; P<.001). Acceptability and feasibility were demonstrated. Conclusions: STAND is a feasible and acceptable model of care that can reach large numbers of individuals. STAND showed preliminary effectiveness on all primary outcome measures. Current directions to improve STAND are described.

7 January 2021 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
KCKelly Chen
Kelly Chen
NBNora Barnes-Horowitz
Nora Barnes-Horowitz
MTMichael Treanor
Michael Treanor
MSMichael Sun
Michael Sun
KYKatherine Young
Katherine Young
MCMichelle G. Craske
Michelle G. Craske
Anhedonia is a risk factor for suicide and poor treatment response in depressed individuals. Most evidence-based psychological therapies target symptoms of heightened negative affect (e.g., negative inferential style) instead of deficits in positive affect (e.g., attenuated reward response) and typically show little benefit for anhedonia. Viewing positive scenes through virtual reality (VR) has been shown to increase positive affect and holds great promise for addressing anhedonic symptoms. In this pilot study, six participants with clinically significant depression completed 13 sessions of exposure to positive scenes in a controlled VR environment. Significant decreases were found in self-reported anhedonia, depression, anxiety, and impairments in functioning from baseline to 1-month follow-up. Negative affect decreased over all 13 sessions, and positive affect increased over sessions 8–13. Results suggest that positive experiences in VR may be a novel avenue for the treatment of anhedonia in depressed individuals.

1 April 2024 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
NBNora M. Barnes-Horowitz
Nora M. Barnes-Horowitz
AMAllison Metts
Allison Metts
DRDavid Rosenfield
David Rosenfield
JYJulia S. Yarrington
Julia S. Yarrington
MTMichael Treanor
Michael Treanor
MCMichelle G. Craske
Michelle G. Craske
Positive and negative affect play critical roles in depression and anxiety treatment, but the dynamic processes of how affect changes over treatment in relation to changes in symptoms is unclear. The study goal was to examine relationships among changes in positive and negative affect with changes in depression and anxiety symptoms. This secondary analysis used a combined sample (N = 196) of two trials (Craske et al., 2019, 2023) comparing positive affect treatment (PAT) to negative affect treatment. Longitudinal cross-lag panel models explored whether changes in positive and negative affect (Positive and Negative Affect Schedule; Watson et al., 1988) predicted subsequent changes in depression and anxiety symptoms (Depression Anxiety Stress Scales; Lovibond & Lovibond, 1995), whether symptoms predicted subsequent changes in affect, and whether treatment condition moderated these relationships. Increases in positive affect predicted subsequent decreases in depression and anxiety symptoms, regardless of treatment condition. Symptoms did not reciprocally predict changes in positive affect. For individuals in PAT, decreases in negative affect predicted subsequent decreases in symptoms. Moreover, decreases in symptoms predicted subsequent decreases in negative affect, regardless of treatment condition. Results did not support a reciprocal relationship between positive affect and symptoms of depression and anxiety since positive affect predicted depression and anxiety symptoms but not vice versa. Results supported a reciprocal relationship between negative affect and symptoms of depression and anxiety since negative affect predicted depression and anxiety symptoms in PAT, and depression and anxiety symptoms predicted negative affect in both treatment conditions. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

1 January 2023 in Journal of Experimental Psychopathology
Verified
Journal Article
Open access
NBNora M. Barnes-Horowitz
Nora M. Barnes-Horowitz
AEAileen Echiverri-Cohen
Aileen Echiverri-Cohen
JRJulian Ruiz
Julian Ruiz
TZTomislav D. Zbozinek
Tomislav D. Zbozinek
RKRebecca Kim
Rebecca Kim
MCMichelle G. Craske
Michelle G. Craske
Cognitive behavioral therapy (CBT) focuses on decreasing negative affect rather than increasing positive affect and is ineffective for some individuals. A trial comparing novel Positive Affect Treatment (PAT) to Negative Affect Treatment (NAT; a form of CBT) showed that PAT more effectively increased positive affect and decreased negative affect, depression, and anxiety (Craske et al., 2019). The present exploratory study examined threat sensitivity as a treatment moderator. Threat sensitivity was operationalized as pre-treatment skin conductance response and unconditional stimulus (US) expectancy rating during extinction recall. Participants ( N = 43) then received 15 sessions of PAT or NAT. Growth curve models were tested to explore interactions between extinction recall and treatment condition over time. For skin conductance, weaker extinction recall predicted faster improvement in depression and anxiety in NAT than PAT, whereas stronger extinction recall predicted faster improvement in symptoms in PAT than NAT. Reduced US expectancy ratings predicted a faster decrease in symptoms, regardless of treatment condition. Individuals showing greater threat sensitivity, indexed by weaker extinction recall, may benefit more from a treatment that targets threat sensitivity than a treatment that targets reward sensitivity. Individuals showing the converse may benefit more quickly from a treatment that targets reward sensitivity than threat sensitivity.

5 July 2025 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
NBNora M. Barnes-Horowitz
Nora M. Barnes-Horowitz
TZTomislav D. Zbozinek
Tomislav D. Zbozinek
MCMichelle G. Craske
Michelle G. Craske

9 October 2026 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
NBN.M. Barnes-Horowitz
N.M. Barnes-Horowitz
OLO.M. Losiewicz
O.M. Losiewicz
CSC.F. Sandman
C.F. Sandman
BRB.M. Rosenberg
B.M. Rosenberg
MTM. Treanor
M. Treanor
MCM.G. Craske
M.G. Craske